Traditional Chinese medicine composition for treating cyclomastopathy, mammary pain and postpartum milk obstruction

Abstract

The invention provides a traditional Chinese medicine composition for treating cyclomastopathy, mammary pain and postpartum milk obstruction. The traditional Chinese medicine composition provided by the invention has the effects of tonifying kidney, soothing the liver, regulating the chong and ren meridians, invigorating blood circulation and removing stasis and is used for treating diseases such as the kidney-asthenia and liver depression type cyclomastopathy, the mammary pain and the postpartum milk obstruction. The traditional Chinese medicine composition is mainly prepared from the following medicinal raw materials in parts by weight: 9-15 parts of cornu cervi degelatinatum, 9-15 parts of cassia twig, 9-15 parts of radix bupleuri, 8-12 parts of snakegourd fruit, 8-12 parts of angelica, 8-12 parts of ligusticum wallichii, 5-9 parts of fructus liquidambaris, 9-15 parts of raw oyster shell, 5-9 parts of flos albiziae and 5-9 parts of raw malt.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating mammary gland hyperplasia, mastalgia and postpartum milk obstruction, and also relates to a preparation method and application of the composition. Background technique [0002] Mammary gland hyperplasia ranks first in the incidence of breast diseases. According to the survey, about 70% to 80% of women have different degrees of mammary gland hyperplasia. About 1 / 3 of women in developed countries suffer from this disease. The data prove that this disease is a precancerous lesion. The chance of suffering from breast cancer is 3 to 5 times that of ordinary women. In recent years, its incidence rate has been increasing year by year, and the age of onset is gradually decreasing. [0003] Mammary gland hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast ...

AI Technical Summary

Problems solved by technology

[0008] Chinese patent document CN1509743A discloses a Xiaru oral liquid, which is formulated with Bupleurum chinensis, Fructus chinensis, Tangerine peel, Angelica, Radix Paeoniae Alba, Rhizoma Chuanxiong, Raw Malt, Loulu, Passepartout, Shanjia, Wangbuliu, and Licorice , this formula focuses on soothing the liver and regulating qi, promoting blood circulation and dredging collaterals, and is only suitable for mammary gland hyperplasia caused by liver depression, qi stagnation and blood stasis

However, the breast belongs to the stomach, and the nipple belongs to the liver. Clinically, the reduction and blockage of breast milk is mostly related to the digestion of the spleen and stomach. If the problem of spleen and stomach movement and transformation is not solved, there is still no biochemical source of qi and blood. Where does milk come from? The above-mentioned drugs cannot effectively solve the above-mentioned problems, and the clinical curative effect is not good

[0010] Chinese patent document CN101716299A discloses a traditional Chinese medicine composition for treating mammary gland hyperplasia, which is made of the following raw materials: 30 grams of oysters, 15 grams of kelp, 15 grams of Bupleurum, 15 grams of astragalus, 15 grams of angelica, and 15 grams of salvia , 15 grams of red peony root, 15 grams of Atractylodes macrocephala, 10 grams of poria cocos, 10 grams of melon wilt seed, 10 grams of chuanxiong, 10 grams of asparagus, 10 grams of trigonum, 10 grams of green peel, 10 grams of orange core, but the above formula drugs are complex and clinically Practice shows that this prescription is only for specific patients, and the curative effect is not good for most patients

[0011] Traditional Chinese medicine has unique advantages in the prevention and treatment of cystic hyperplasia of the breast, mastalgia, and postpartum milk obstruction. However, due to the unclear pathogenesis of such diseases, most Chinese patent medicines on the market are simply tonifying the kidney, attacking, regulating qi, and dispelling stagnation. Mainly, poor long-term efficacy

Images